Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kakkis Emil D
Relationship:  
City:   Novato
State:   CA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   603,534    

Indirect Shares

   2,268,639      
Direct Value   $26,857,607    

Indirect Value

   $94,141,463      
Total Shares   2,872,173      
Total Value   $120,999,070      


Biomarin Pharmaceutical Inc $3,511,609 Ultragenyx Pharmaceutical Inc $23,345,998 Biomarin Pharmaceutical Inc $3,511,609 Ultragenyx Pharmaceutical Inc $23,345,998
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Chief Medical Officer 2009-03-02 39,621 2009-03-02 4,654    Premium*  
            Ultragenyx Pharmaceutical Inc RARE 2024-03-01 563,913 2024-03-01 2,263,985    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2017-08-28 4 B $52.40 $393,922 I/I 7,500 2,559,741 2.66 -
RARE Ultragenyx Pharmaceutical... See RemarksOfficer   •       •       •   2014-01-30 3 IO $0.00 $0 I/I 0 2,552,241 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2020-07-13 4 AS $85.35 $3,414,000 I/I (40,000) 2,419,741 0 %
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2020-09-01 4 AS $82.63 $2,478,900 I/I (30,000) 2,389,741 0 %
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2020-11-02 4 AS $96.82 $2,904,600 I/I (30,000) 2,359,741 0 %
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2021-01-04 4 AS $136.90 $4,107,000 I/I (30,000) 2,329,741 0 %
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2021-03-01 4 AS $141.80 $4,254,000 I/I (30,000) 2,289,741 0 %
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2021-05-03 4 AS $107.80 $3,234,000 I/I (30,000) 2,259,741 0 %
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2020-03-12 4 OE $3.01 $449,998 D/D 149,700 654,500 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2020-04-19 4 D $58.57 $49,843 D/D (851) 653,649 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2020-05-06 4 D $66.26 $56,454 D/D (852) 652,797 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2023-10-19 4 OE $6.86 $328,272 D/D 47,853 647,029 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2015-05-21 4 A $0.00 $0 D/D 11,400 635,640 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2022-03-01 4 A $0.00 $0 D/D 52,041 634,226 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •       •   2014-02-05 4 A $0.00 $0 D/D 624,240 624,240 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2015-10-30 4 AS $98.63 $1,991,407 D/D (20,000) 615,640 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2023-03-01 4 A $0.00 $0 D/D 54,916 615,606 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2021-03-01 4 A $0.00 $0 D/D 33,453 612,394 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2020-06-01 4 D $69.38 $92,553 D/D (1,334) 611,041 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2020-10-14 4 D $92.69 $78,972 D/D (852) 610,189 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2023-10-19 4 AS $33.52 $1,604,033 D/D (47,853) 599,743 0 %
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2023-03-01 4 D $45.65 $736,791 D/D (16,140) 599,176 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2021-03-01 4 D $142.47 $2,328,245 D/D (16,342) 596,052 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2015-11-30 4 AS $96.46 $1,965,427 D/D (20,000) 595,640 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2021-05-06 4 D $115.71 $98,585 D/D (852) 595,200 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us